Addis Ababa, July 18, 2025 (FMC) — Ethiopia has renewed its commitment to becoming Africa’s top pharmaceutical export hub, as government officials and development partners convened at Kilinto Pharmaceutical Industrial Park to assess progress and accelerate reforms.
State Minister of Finance, Semereta Sewasew, highlighted Ethiopia’s investment in specialized industrial parks with ready-made facilities and tailored infrastructure to reduce startup costs and attract pharmaceutical manufacturers. She underscored the sector’s importance for import substitution, job creation, and access to affordable medicines.
While acknowledging initial challenges, Semereta stressed that upcoming reforms will focus on improving the regulatory environment, streamlining drug approvals, and aligning standards with regional frameworks to boost investor confidence and export capacity.
The government is also offering incentives—including tax breaks, duty exemptions, and subsidized electricity—while supporting skills development and public-private partnerships to advance local production.
World Bank official Maryam Salim reaffirmed the Bank’s strong support, noting Ethiopia is among five global priorities for pharmaceutical development. “We’re placing our bets on Ethiopia,” she said, pledging continued partnership.
The delegation toured Africure Pharmaceuticals, where CEO Dr. Tadesse Teferi called for increased financing to bridge working capital gaps and support export growth.
IPDC CEO Dr. Fisseha Yitagessu identified key infrastructure gaps—such as energy and waste management—that must be addressed to ensure reliable, compliant production. He and others emphasized the need for sustained investment and logistical improvements across the value chain.
The Ministry of Finance reaffirmed its full backing for the sector’s growth, calling on partners like the World Bank and IFC to strengthen long-term support. Officials noted that a thriving pharmaceutical industry could serve as a blueprint for Ethiopia’s broader industrial ambitions.